EUVIMEDEUVIMED entdecken
Crossref

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis

Yajun Shen, Zixuan You, Lingyu Li, Xiaofei Tang, Xiaofeng Shan iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Yajun Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clini…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mice, Nude, Mouth Neoplasms, Peroxiredoxins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxiredoxin 1 (PRDX1) is an important member of the peroxiredoxin family (PRDX) and is upregulated in a variety of tumors. Previous studies have found that high PRDX1 expression is closely related to the metastasis of oral squamous cell carcinoma (OSCC), but the specific molecular mechanism is elusive. To elucidate the role of PRDX1 in the metastasis process of OSCC, we evaluated the expression of PRDX1 in OSCC clinical specimens and its impact on the prognosis of OSCC patients. Then, the effect of PRDX1 on OSCC metastasis and cytoskeletal reconstruction was explored in vitro and in nude mouse tongue cancer models, and the molecular mechanisms were also investigated. PRDX1 can directly interact with the actin‐binding protein Cofilin, inhibiting the phosphorylation of its Ser3 site, accelerating the depolymerization and turnover of actin, promoting OSCC cell movement, and aggravating the invasion and metastasis of OSCC. In clinical samples and mouse tongue cancer models, PRDX1 also increased lymph node metastasis of OSCC and was negatively correlated with the phosphorylation of Cofilin; PRDX1 also reduced the overall survival rate of OSCC patients. In summary, our study identified that PRDX1 may be a potential therapeutic target to inhibit OSCC metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMice, NudeMouth NeoplasmsPeroxiredoxinsAnimalsFemaleHumansMaleMiceMiddle AgedActin Depolymerizing FactorsCell Line, TumorCell MovementCofilin 1Gene Expression Regulation, NeoplasticLymphatic MetastasisMice, Inbred BALB CPhosphorylationPrognosisTongue Neoplasms

Stichwörter der Autor:innen

CofilinOSCCmetastasisperoxiredoxin 1

Substanzen

Actin Depolymerizing FactorsCofilin 1PeroxiredoxinsPRDX1 protein, humanPrdx1 protein, mouse

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research…
  • Department of Oral Pathology, Beijing Stomatological Hospital & School of Stomatology, Capital Medical University, Beijing, China.
  • Division of Oral Pathology, Beijing Institute of Dental Research, Beijing Stomatological Hospital & School of Stomatology, Capital Medical University, Beijing, China.

ORCID-Profile: Xiaofeng Shan

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Shen, Y., You, Z., Li, L., Tang, X., & Shan, X. (2024). The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis. International Journal of Cancer. https://doi.org/10.1002/ijc.34999

Vancouver

Shen Y, You Z, Li L, Tang X, Shan X. The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis. International Journal of Cancer. 2024. doi:10.1002/ijc.34999

BibTeX
@article{Shen2024,
  author = {Shen, Yajun and You, Zixuan and Li, Lingyu and Tang, Xiaofei and Shan, Xiaofeng},
  title = {The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34999}
}
Kostenlos starten →